Table 2.
Variables | Hazard Ratio | Std. Err. | z | P > z | 95% Conf. Interval | |
---|---|---|---|---|---|---|
Overall survival | ||||||
Gender | 0.819069 | 0.118835 | −1.38 | 0.169 | 0.616344 | 1.088473 |
Age | 1.085215 | 0.164879 | 0.54 | 0.59 | 0.805732 | 1.461641 |
Differentiation | 0.861365 | 0.083491 | −1.54 | 0.124 | 0.71233 | 1.04158 |
TNM stage (AJCC) | 1.962722 | 0.359883 | 3.68 | 0.003** | 1.370197 | 2.811476 |
Lymph‐node metastasis | 1.259477 | 0.20096 | 1.45 | 0.148 | 0.921242 | 1.721895 |
Perineural invasion | 0.584926 | 0.222848 | −1.41 | 0.159 | 0.277208 | 1.23423 |
HIF‐2α level | 1.418071 | 0.217761 | 2.27 | 0.023* | 1.049509 | 1.916061 |
Progression‐free survival | ||||||
Gender | 0.912942 | 0.131993 | −0.63 | 0.529 | 0.687664 | 1.212021 |
Age | 0.874395 | 0.134805 | −0.87 | 0.384 | 0.646366 | 1.182869 |
Differentiation | 0.840913 | 0.081486 | −1.79 | 0.074 | 0.695454 | 1.016796 |
TNM stage (AJCC) | 1.79714 | 0.333591 | 3.16 | 0.002** | 1.249047 | 2.58574 |
Lymph‐node metastasis | 1.417982 | 0.225453 | 2.2 | 0.028* | 1.038325 | 1.936459 |
Perineural invasion | 0.724537 | 0.280056 | −0.83 | 0.404 | 0.339661 | 1.545525 |
HIF‐2α level | 1.358757 | 0.208601 | 2 | 0.046* | 1.005685 | 1.835783 |
*P < 0.05, **P < 0.01.